SecBot SecBot
SECBOTREPLAY Home › Report › TEM

TEM · Precision oncology military pact

SOTERIA Precision Medicine Foundation · PRESS-RELEASE filed Nov 9, 2026 at 16:39 ET

At the news

NEUTRALIMPACT 3/10

PRESS-RELEASE filed Nov 9, 2026 at 16:39 ET

SOTERIA Precision Medicine Foundation announced a collaboration with Tempus to provide genomic sequencing and AI-enabled diagnostic support for precision oncology care to U.S. active-duty and veteran military populations. The partnership expands Tempus's platform into a new patient cohort but does not disclose any financial terms, revenue commitments, or volume guarantees.

  • Collaboration with SOTERIA Precision Medicine Foundation, a non-profit, to deliver genomic profiling and AI diagnostics to military cancer patients
  • No financial terms, contract value, or revenue commitments disclosed in the release
  • Tempus's platform will support SOTERIA's Cancer Hunt initiative for active-duty and veteran populations
  • Partnership is non-exclusive and no stated minimum volume or duration

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access